期刊文献+

持续不卧床腹膜透析患者蛋白质-能量消耗与同型半胱氨酸关系的探讨 被引量:1

Relationship between protein energy expenditure and homocysteine in Continuous ambulatory peritoneal dialysis patients
下载PDF
导出
摘要 目的:探讨持续不卧床腹膜透析(CAPD)患者蛋白质-能量消耗(PEW)与血同型半胱氨酸水平(Hcy)的关系。方法:收治CAPD患者82例,根据血Hcy水平分为A组、B组。结果:两组改良主观全面营养评估(MQSGA)积分、血白蛋白(ALB)、前白蛋白(PA)、C反应蛋白(CRP)比较,差异有统计学意义(P<0.05);A组治疗前后Hcy、MQSGA积分、血白蛋白(ALB)、前白蛋白(PA)、CRP比较差异有统计学意义(P<0.05);Hcy与MQSGA、CRP呈正相关(r=0.371,r=0.331,P<0.05)。结论:持续不卧床CAPD患者普遍存在高同型半胱氨酸血症,血同型半胱氨酸水平对蛋白质-能量消耗的评估及诊治具有一定意义。 Objective:To explore the relationship between protein energy expenditure(PEW)and homocysteine(HCY)in Continuous ambulatory peritoneal dialysis patients(CAPD).Methods:82 patients with CAPD were selected,they were divided into the A group and the B group according to HCY level.Results:The scores of improved subjective comprehensive nutrition assessment(MQSGA),serum albumin(ALB),prealbumin(PA)and C-reactive protein(CRP)were significantly different between the two groups(P<0.05).There were significant differences in HCY,MQSGA score,serum albumin(ALB),prealbumin(PA)and CRP before and after treatment in the A group(P<0.05).HCY was positively correlated with MQSGA and CRP(r=0.371,r=0.331,P<0.05).Conclusion:Hyperhomocysteinemia was common in CAPD patients,blood homocysteine level had a certain significance in the evaluation and diagnosis of protein energy expenditure.
作者 王永业 Wang Yongye(Department of Nephrology,Cangnan Hospital Affiliated to Wenzhou Medical University(Zhejiang)325800)
出处 《中国社区医师》 2018年第30期90-91,共2页 Chinese Community Doctors
基金 卫生高层次浙江省医坛新秀人才培养计划项目(2016-2018)~~
关键词 同型半胱氨酸 腹膜透析 蛋白质-能量消耗 Homocysteine Peritoneal dialysis Protein energy expenditure
  • 相关文献

参考文献4

二级参考文献74

  • 1赵建荣,黄宇玮,茆亦一,陆强.高血压病患者血浆同型半胱氨酸与血脂关系研究[J].实用全科医学,2007,5(1):5-6. 被引量:32
  • 2Tremblay R, Bonnardeaux A, Geadah D Hyperhomocysteinemia in hemodialysis patients: 12-month supplementation with hydro soluble Kidney Int, 2000, 58: 851-858. et al. effects of.
  • 3Massy ZA, Ceballos I, Chadefaux-Vekemens B, et al. Homocysteine, oxidative stress, and endothelium function in uremic patients. Kidney Int Suppl, 2001, 78: 243-245.
  • 4Perma AF, Ingrosso D, Castaldo P, et al. Homocysteine and chromic renal failure. Miner Electrolyte Metab, 1999, 25: 279-285.
  • 5Biasioli S, Schiavon R. Homocysteine as a cardiovascular risk factor. Blood Purif, 2000, 18: 177-182.
  • 6Tamura T, Johnston K, Bergman SM. Homocysteine and folate concentrations in blood from patients treated with hemodialysis. J Am Soc Nephrol, 1996, 7: 2414-2418.
  • 7Chambers TC, Ueland PM, Wright M, et al. Investigation of relationship between reduced, oxidized, and protein-bound homocysteine and vascular endothelial function in healthy human subject. Circ Res, 2110, 89: 187-192.
  • 8Bostom AG, shemin D, lapane KL, et al. Hyperhomocysteinmia and traditional cardiovascular disease risk. Factors on dialysis case-control study. Atherosclosis, 1995, 11: 9.
  • 9Arnadottir M, Berg AL, Heghrant T, et al. Influence of hemodialysis on plasma total homocysteine concentration. Nephrol Dial Transplant, 1999, 14: 142-146.
  • 10Van Guldener C, Kulik W, Berger R, et al. Homocysteine and methionine metabolism in ESRD: a stable isotope study. Kidney Int, 1999, 56: 1064-1071.

共引文献151

同被引文献1

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部